Two types of LMW heparin were prepared by gel filtration of standard heparin (LMW fraction) and by degradation of heparin by nitrous acid (LMW fragment), respectively. The effects on factor Xa inhibition (XaI), APTT, platelet aggregation and AT III level of these preparations were studied after subcutaneous administration to humans and compared with those of standard heparin. At a dose of 5000 IU (XaI) the LMW fraction and LMW fragment induced peak plasma XaI activity of 0.32 IU/ml and 0.41 IU/ml respectively, compared to 0.07 IU/ml for heparin. Still 11.5 h after administration both LMW preparations gave higher activities than heparin ever induced. Following administration of 10,000 IU (XaI) of the LMW fragment the plasma peak XaI activity was 0.81 IU/ml. This prolonged the APTT from 36 sec to 46 sec only. The half-lives of the XaI activity in plasma were between 3 and 4 hours. No effect on platelet aggregation or AT-III level was demonstrated.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/0049-3848(83)90091-9 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Differential effects of purified low molecular weight Poly(I:C) in the maternal immune activation model depend on the laboratory environment.
Transl Psychiatry
July 2024
Department of Neurophysiology and Neuropharmacology, Medical University of Vienna, Vienna, Austria.
The Poly (I:C) (polyriboinosinic-polyribocytidilic acid) paradigm of maternal immune activation (MIA) is most widely used as experimental model for the evaluation of the effects of gestational infection on the brain and behavior of the progeny. We have previously reported significant batch-to-batch variability in the effects of Poly (I:C), purchased from the same supplier (Sigma-Aldrich), on maternal and fetal immune responses and found these differences to be dependent on the relative amount of synthetic double-stranded RNA fragments in the high versus low molecular weight (LMW) range contained in the compound. We here resorted to Poly (I:C) purified for LMW dsRNA fragments to establish a MIA paradigm with increased reproducibility and enhanced standardization in an effort to refine the MIA paradigm and characterize its effect on offspring behavior.
View Article and Find Full Text PDFAntibodies expand the scope of angiotensin receptor pharmacology.
Nat Chem Biol
December 2024
Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
Article Synopsis
- G-protein-coupled receptors (GPCRs) play a crucial role in regulating human physiology and are common targets for drugs, but selective binding of drugs to GPCRs is often limited.
- Researchers developed specialized heavy-chain-only antibodies, known as 'nanobodies', that can selectively act as antagonists for the angiotensin II type I receptor, revealing unique mechanisms of how they block receptor activity.
- The study demonstrates that these nanobodies can co-bind with small-molecule antagonists, providing a way to finely tune ligand selectivity, and highlights the potential of antibody fragments as advanced modulators for GPCRs in drug development.
Accelerated development of a SEC-HPLC procedure for purity analysis of monoclonal antibodies using design of experiments.
J Chromatogr B Analyt Technol Biomed Life Sci
March 2024
Catalent Biologics, Madison, WI, USA.
The complex structure of biopharmaceutical products poses an inherent need for their thorough characterization to ensure product quality, safety, and efficacy. Analytical size exclusion chromatography (SEC) is a widely used technique throughout the development and manufacturing of monoclonal antibodies (mAbs) which quantifies product size variants such as aggregates and fragments. Aggregate and fragment content are critical quality attributes (CQAs) in mAb products, as higher contents of such size heterogeneities impact product quality.
View Article and Find Full Text PDFCharacterization, Bioactivity, and Biodistribution of 35 kDa Hyaluronan Fragment.
Life (Basel)
January 2024
Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX 77030, USA.
It has been reported that hyaluronic acid (HA) with a 35 kDa molecular weight (HA35) acts biologically to protect tissue from injury, but its biological properties are not yet fully characterized. This study aimed to evaluate the cellular effects and biodistribution of HA35 compared to HA with a 1600 kDa molecular weight (HA1600). We assessed the effects of HA35 and HA1600 on cell migration, NO and ROS generation, and gene expression in cultured macrophages, microglia, and lymphocytes.
View Article and Find Full Text PDFLow-molecular-weight fucoidan inhibits the proliferation of melanoma via Bcl-2 phosphorylation and PTEN/AKT pathway.
Oncol Res
January 2024
Department of Mechanical Engineering, Tech University of Korea, Si-heung City, 15073, Korea.
Fucoidan, a sulfate polysaccharide obtained from brown seaweed, has various bioactive properties, including anti-inflammatory, anti-cancer, anti-viral, anti-oxidant, anti-coagulant, anti-thrombotic, anti-angiogenic, and anti- properties. However, the effects of low-molecular-weight fucoidan (LMW-F) on melanoma cell lines and three dimensional (3D) cell culture models are not well understood. This study aimed to investigate the effects of LMW-F on A375 human melanoma cells and cryopreserved biospecimens derived from patients with advanced melanoma.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!